India  

DCGI nod for Covaxin human trials

Hindu Monday, 29 June 2020
Indigenous vaccine trials start in July
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak [Video]

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

The first part of phase-1 of Covaxin human trial completed on Saturday. The trial was conducted at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal..

Credit: HT Digital Content     Duration: 02:37Published
Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak [Video]

Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak

Human trials of a Covid vaccine candidate, developed in India, have begun. Trials of the drug named Covaxin are being conducted at PGIMS, Rohtak. Bharat Biotech and ICMR's National Institute of..

Credit: HT Digital Content     Duration: 02:50Published
Covid vaccine: India begins first stage Covaxin human trials | Oneindia News [Video]

Covid vaccine: India begins first stage Covaxin human trials | Oneindia News

BJP seeks CBI probe into Congress 'phone tapping'; Congress asks why Sachin Pilot trusts Haryana cops, alleges BJP engineered split; Global Covid cases jump by 1 million in less than 100 hours; India's..

Credit: Oneindia     Duration: 02:31Published

Related news from verified sources

India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
IndiaTimes

DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human...
Mid-Day


Tweets about this